10 ADHD Clinical Trials in Birmingham, MI (2026)

Q: How do I join a clinical trial in Birmingham?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you.

Recruiting ADHD Studies in Birmingham

NCT02660645Recruiting

Blue Light Cystoscopy With Cysview® Registry

Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices....

Birmingham, MI4,400 participantsPhotocure

View Study Details

NCT05059444Recruiting

ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation

The purpose of ORACLE is to demonstrate the ability of a novel ctDNA assay developed by Guardant Health to detect recurrence in individuals treated for early-stage solid tumors. It is necessary that c...

Birmingham, MI2,285 participantsGuardant Health, Inc.

View Study Details

NCT06605404Recruiting

Pan-tumor MRD Study

The purpose of this observational study is to collect clinical information, blood, and tumor tissue samples from participants diagnosed with stage I, stage II, or operable stage III cancer in select s...

Birmingham, MI1,350 participantsParadigm Health

View Study Details

NCT06797245Recruiting

APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women

The APPROVE trial is a multi-centered, randomized controlled trial designed to assess differences in symptom improvement, quality of life, bladder symptoms, satisfaction with treatment and continued t...

Birmingham, MINA596 participantsMedstar Health Research Institute

View Study Details

NCT04752722Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

This study will evaluate the safety and efficacy of intravesical administration of EG-70 in the bladder and its effect on bladder tumors in patients with NMIBC. This study study consists of two phase...

Birmingham, MIPHASE1350 participantsenGene, Inc.

View Study Details

NCT07000084Recruiting

Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy

This phase III trial compares the effect of adding gemcitabine to intravesical Bacillus Calmette Guerin (BCG) versus intravesical BCG alone in patients with non-muscle invasive bladder cancer that has...

Birmingham, MIPHASE3330 participantsAlliance for Clinical Trials in Oncology

View Study Details

NCT07206225Recruiting

A Study to Learn About the Study Medicine PF-08052667 in People With Bladder Cancer

The purpose of this study is to learn how a new medicine called PF-08052667 works when used by itself or together with another medicine called Bacillus Calmette Guerin (BCG), and/or a medicine called ...

Birmingham, MIPHASE1294 participantsPfizer

View Study Details

NCT06511141Recruiting

Sacral Neuromodulation for Male Overactive Bladder (MOAB)

To assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients....

Birmingham, MINA150 participantsAxonics, Inc.

View Study Details

NCT07309445Recruiting

A Study to Assess Real-World Use and Outcomes of TAR-200 for Participants With Non-Muscle Invasive Bladder Cancer (NMIBC) in the United States

The purpose of this study is to assess how well TAR-200 works in real-word by measuring the time taken from the first TAR-200 insertion to worsening of cancer or until the signs and symptoms of cancer...

Birmingham, MI150 participantsJanssen Research & Development, LLC

View Study Details

NCT07061964Recruiting

Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial

This phase II trial tests the effect of giving pembrolizumab in combination with radiation therapy after chemotherapy in preventing surgery to remove the bladder in patients with muscle invasive bladd...

Birmingham, MIPHASE2111 participantsNational Cancer Institute (NCI)

View Study Details

About ADHD Clinical Trials in Birmingham

Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by inattention, hyperactivity, and impulsivity that interferes with functioning. It affects both children and adults. Treatment includes behavioral therapy, stimulant and non-stimulant medications, and educational support.

There are currently 10 adhd clinical trials recruiting participants in Birmingham, MI. These studies are seeking a combined 10,016 participants. Research is being sponsored by Photocure, Guardant Health, Inc., Paradigm Health and 7 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

ADHD Clinical Trials in Birmingham — FAQ

Are there adhd clinical trials in Birmingham?

Yes, there are 10 adhd clinical trials currently recruiting in Birmingham, MI. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Birmingham?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Birmingham research site will contact you about next steps.

Are clinical trials in Birmingham free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Birmingham studies also compensate for your time and travel.

What adhd treatments are being tested?

The 10 active trials in Birmingham are testing new therapies including novel drugs, biologics, and treatment approaches for adhd.

Data updated October 12, 2026 from ClinicalTrials.gov